COVID-19 Blog - Microbix

Microbix Announces Annual and Special Meeting Voting Results

Apr 1, 2024

MISSISSAUGA, April 1, 2024 - Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF) (“Microbix®” or the Company”), a life sciences innovator...

Mar 15, 2024

Sequel Pharma Executes Agreement with CDMO for Drug Substance Production MISSISSAUGA, CANADA, March 14, 2024 – Microbix Biosystems Inc....

Mar 11, 2024

HPV-related Tissue-Sample Mimics for QC of histology and PCR analyses MISSISSAUGA, CANADA, March 11, 2024 – Microbix Biosystems Inc. (TSX:...

Mar 7, 2024

ISO 13485:2016 Medical Devices Certification Attained TORONTO, December 24, 2018 - Microbix Biosystems Inc. (TSX: MBX, Microbix®), an...

Feb 14, 2024

Record Revenues of $8.4 million and Record Net Income of $2.5 million MISSISSAUGA, CANADA, February 14, 2024 - Microbix Biosystems Inc....

Feb 11, 2024

Microbix will be hosting a virtual AGM on March 27, 2024, at 1:00 pm. The online link will allow shareholders to listen to the AGM and...

Feb 7, 2024

Results Release and Webinar Discussion on Morning of February 14, 2024 MISSISSAUGA, CANADA, February 7, 2024 - Microbix Biosystems Inc....

Feb 6, 2024

FLOQSwab-formatted QAP Supporting MDx Tests for H. pylori MISSISSAUGA, CANADA, February 6, 2024 – Microbix Biosystems Inc. (TSX: MBX,...

Jan 3, 2024

Over C$ 1 Million in One Shipment to a Leading Lab Accreditation Agency MISSISSAUGA, CANADA, January 3, 2024 – Microbix Biosystems Inc....

Dec 21, 2023

Full-Year Sales of $16.5 million and Net Loss of $0.04 million MISSISSAUGA, CANADA, December 21, 2023 - Microbix Biosystems Inc. (TSX:...